Physiological effect of a probiotic on skin

Journal of Cosmetic Science

Volumn 63, Issue 6, 2012, Pages 385-395

  Muizzuddin, Neelam ^a   Maher, Wanda ^a   Sullivan, Michael ^a   Schnittger, Steven ^a   Mammone, Thomas ^a  

^a Estee Lauder Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PROBIOTIC AGENT; TRICLOSAN; WATER;

ACNE VULGARIS; ARTICLE; BACTERIAL LOAD; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; DRUG MIXTURE; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; LACTOBACILLUS PLANTARUM; MALE; METABOLISM; PATHOLOGY; SKIN; SKIN TEST; TRANSPORT AT THE CELLULAR LEVEL;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; BIOLOGICAL TRANSPORT; COMPLEX MIXTURES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LACTOBACILLUS PLANTARUM; MALE; PROBIOTICS; SKIN; SKIN TESTS; TRICLOSAN; WATER;

EID: 84873958163     PISSN: 15257886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. E. Metchnikoff, The Prolongation of Life, Optimistic Studies (Putnam’s Sons, New York, 1908), pp. 161–183.
2. D. M. Lilly and R. H. Stillwell, Probiotics: growth-promoting factors produced by microorganisms, Science, 147, 747–748 (1965).
3. P. Marteau, E. Cuillerier, S. Meance, M. F. Gerhardt, A. Myara, M. Bouvier, C. Bouley, F. Tondu, G. Bommelaer, and J. C. Grimaud, Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study, Aliment Pharmacol Ther., 16, 587–593 (2002).
4. B. S. Gan, J. Kim, G. Reid, P. Cadieux, and J. C. Howard, Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats, J Infect Dis., 185(9), 1369–1372 (2002).
5. B. Karska-Wysocki, M. Bazo, and W. Smoragiewicz, Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA), Microbiol Res., 165(8), 674–686 (2010).
6. R. S. Ali, A. Falconer, M. Ikram, C. E. Bissett, R. Cerio, and A. G. Quinn, Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin, J Invest Dermatol., 117(1), 106–111 (2001).
7. M. Frye, J. Bargon, and R. Gropp, Expression of human beta-defensin-1 promotes differentiation of keratinocytes, J Mol Med., 79(5–6), 275–282 (2001).
8. T. Tomita and T. Nagase, Defensins as a mechanism of host defense and innate immunity, Nippon Ronen Igakkai Zasshi, 38(4), 440–443 (2001).
9. Y. Sang and F. Blecha, Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics, Anim Health Res Rev., 9(2), 227–235 (2008).
10. H. Baba, A. Masuyama, C. Yoshimura, Y. Aoyama, T. Takano, and K. Ohki, Oral intake of Lactobacillus helveticus-fermented milk whey decreased transepidermal water loss and prevented the onset of sodium dodecylsulfate-induced dermatitis in mice, Biosci Biotechnol Biochem., 74(1), 18–23 (2010).
11. A. Yamamoto, K. Takenouchi, and M. Ito, Impaired water barrier function in acne vulgaris, Arch Dermatol Res., 287(2), 214–8 (1995).
12. N. Muizzuddin, “Acne: Causes, Treatment and Myths,” in Dermatology Research Focus on Acne Melanoma and Psoriasis, D. E. Roth. Ed. (Nova Science Publishers, New York, 2009), pp. 97–106.
13. P. Lyte, R. Sur, A. Nigam, and M. D. Southall, Heat-killed Propionibacterium acnes is capable of inducing inflammatory responses in skin, Exp Dermatol., 18(12), 1070–1072 (2009).
14. M. Sullivan, S. Schnittger, T. Mammone, and E. Goyarts, Skin treatment method with lactobacillus extract, U.S. Patent 7,510,734,B2 (2009).
15. N. Muizzuddin, K. D. Marenus, and D. H. Maes, Factors defining sensitive skin and its treatment, Am J Contact Dermat., 9(3), 170–175 (1998).
16. C. Matthies, A. Dooms-Goossens, J. M. Lachapelle, A. Lahti, T. Menne, I. R. White, and J. Wilkinson, Patch testing with fractionated balsam of Peru, Contact Dermatitis, 19, 384–385 (1988).
17. B. M. Hausen, T. Simatupang, G. Bruhn, P. Evers, and W. A. Koenig, Identification of new allergen constituents and proof of evidence for coniferyl benzoate in Balsam of Peru, Am J Contact Dermat., 6(4), 199–208 (1995).
18. The United States Pharmacopeial Convention, Microbial Limit Tests in United States Pharmacopeia, 27th revision/National Formulary, 22th Ed. (The United States Pharmacopeial Convention, Inc., Rockville, MD, 2003).
19. P. M. Elias, Epidermal lipids, barrier function, and desquamation, J Invest Dermatol., 80 (Suppl), 44s–49s (1993).
20. G. Grubauer, P. M. Elias, and K. R. Feingold, Transepidermal water loss: the signal for recovery of barrier structure and function, J Lipid Res., 30(3), 323–33 (1989).
21. G. Grove, “Age Related Differences in Healing of Superficial Skin Wounds in Humans,” in The Effects of Aging in Oral Mucosa and skin, C. A. Squier and M. W. Hill. Eds. (CRC Press, Boca Raton, FL, 1994), pp. 124–125.
22. N. Muizzuddin, D. H. Maes, and T. Mammone, A rapid method to clinically assess the effect of an antiacne formulation, J. Cosmet. Sci., 60, 25–29 (2009).
23. E. Begon, O. Chosidow, and P. Wolkenstein, Disulone, Ann Dermatol Venereol., 131(12), 1062–1073 (2004).
24. L. H. Kircik, Harnessing the anti-inflammatory effects of topical dapsone for management of acne, J Drugs Dermatol., 9(6), 667–671 (2010).
25. M. Viljanen, E. Savilahti, T. Haahtela, K. Juntunen-Backman, R. Korpela, T. Poussa, T. Tuure, and M. Kuitunen, Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial, Allergy, 60(4), 494–500 (2005).
26. T. Ogawa, S. Hashikawa, Y. Asai, H. Sakamoto, K. Yasuda, and Y. Makimura, A new synbiotic, Lactobacillus casei subsp. casei together with dextran, reduces murine and human allergic reaction, FEMS Immunol Med Microbiol., 46(3), 400–409 (2006).
27. W. P. Bowe and A. C. Logan, Acne vulgaris, probiotics and the gut-brain-skin axis—back to the future, Gut Pathog., 3(1), 1–4 (2011).
28. S. P. Yazdankhah, A. A. Scheie, E. A. Høiby, B. T. Lunestad, E. Heir, T. Ø. Fotland, K. Naterstad, and H. Kruse, Triclosan and antimicrobial resistance in bacteria: an overview, Microb Drug Resist., 12(2), 83–90 (2006).